ellipticine and trichostatin a

ellipticine has been researched along with trichostatin a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dvorakova, M; Eckschlager, T; Frei, E; Göttlicherova, M; Hrabeta, J; Hrebackova, J; Kizek, R; Kopejtkova, B; Moserova, M; Poljakova, J; Stiborova, M	1

Other Studies

1 other study(ies) available for ellipticine and trichostatin a

Article	Year
Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. Neuro endocrinology letters, 2011, Volume: 32 Suppl 1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; DNA Damage; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ellipticines; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Microsomes, Liver; Models, Biological; Neuroblastoma; Rats; Treatment Outcome; Tumor Cells, Cultured; Valproic Acid	2011

Article

Year

Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.

Neuro endocrinology letters, 2011, Volume: 32 Suppl 1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; DNA Damage; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ellipticines; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Microsomes, Liver; Models, Biological; Neuroblastoma; Rats; Treatment Outcome; Tumor Cells, Cultured; Valproic Acid

2011